Novo Nordisk to cut 9,000 jobs, posts another profit warning as it refocuses on core medsnews2025-09-10T11:15:22+00:00September 10th, 2025|Endpoints News|
J&J’s ‘pretzel’ drug-device therapy wins US approval for certain bladder cancersnews2025-09-10T11:01:02+00:00September 10th, 2025|Endpoints News|
Trump directs more FDA enforcement of pharma adsnews2025-09-09T22:57:25+00:00September 9th, 2025|Endpoints News|
Endpoints livestream: Will the XBI ever go up again? news2025-09-09T18:20:48+00:00September 9th, 2025|Endpoints News|
Lundbeck to transfer commercial drugs to three partners in 27 marketsnews2025-09-09T18:08:18+00:00September 9th, 2025|Endpoints News|
HHS outlines vaccine, drug strategy in new MAHA reportnews2025-09-09T18:00:02+00:00September 9th, 2025|Endpoints News|
Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer news2025-09-09T16:38:49+00:00September 9th, 2025|Endpoints News|
Regeneron and Sandoz patent deal clears path for Eylea biosimilar in 2026news2025-09-09T16:33:37+00:00September 9th, 2025|Endpoints News|
Trump may exempt some pharma products from tariffs in future trade dealsnews2025-09-09T15:30:14+00:00September 9th, 2025|Endpoints News|
Novartis to spend $1.4B on Tourmaline Bio, gaining new heart drugnews2025-09-09T10:47:20+00:00September 9th, 2025|Endpoints News|
